The production of extracellular VIM and CK from immune and endothelial cells, which are both involved in carcinoma progression, could contribute to the higher levels of extracellular intermediate filaments in the serum of cancer patients relative to healthy donors [92,93,96,97,98,99,100]. This evidence concerns the gene VIM and cancer.